SOL Global closes latest investment in European Cannabis Holdings

2 minute read
27 February 2019

On Feb. 27, 2019 SOL Global Investments Corp. (CSE: SOL) (OTCQB: SOLCF) (Frankfurt: 9SB) announced the closing of its latest investment in European Cannabis Holdings ("ECH"). The newly-acquired ordinary shares bring SOL Global's total position in ECH to approximately 19.4% of the total issued and outstanding ordinary shares of ECH.

ECH is an unrivalled group of companies at the forefront of the European cannabis industry. Its portfolio includes market intelligence firm Prohibition Partners, Europe's leading medical cannabis conference Cannabis Europa, CBD brand house Amkeu, online learning platform The Academy of Medical Cannabis and UK private clinic chain The Medical Cannabis Clinics.

SOL Global is an international investment company with a focus on, but not limited to, cannabis and cannabis related companies in legal US states, the hemp and CBD marketplaces and the emerging European cannabis and hemp marketplaces. Its strategic investments and partnerships across cultivation, distribution and retail complement the company's R&D program with the University of Miami. It is this comprehensive approach that is positioning SOL Global as a future frontrunner in the medical cannabis industry in the US.

Gowling WLG advised SOL Global with respect to this investment with a team led by Peter Simeon and that included Josh Almario and Amanda Stevens.

NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.